{
    "code": "02020227",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020227",
    "time": "2020-02-25 12:24:13",
    "許可證字號": "衛署藥輸字第020227號",
    "註銷狀態": "已註銷",
    "註銷日期": "92\/07\/31",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "92\/06\/10",
    "發證日期": "82\/12\/29",
    "許可證種類": "製　劑",
    "舊證字號": "02015327",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202022707",
    "中文品名": "克力淨錠",
    "英文品名": "GLIRETIN TABLETS",
    "適應症": "急性或過敏性鼻炎伴生之諸症狀（打噴嚏、流鼻水、鼻塞、）之緩解。",
    "劑型": "110錠劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "07須經醫師指示使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHLORPHENIRAMINE MALEATE, PYRIDOXINE HCL, GLYCYRRHIZINATE DIPOTASSIUM (EQ TO DIPOTASSIUM GLYCYRRHIZINATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "0810601100  佳德興業股份有限公司",
    "申請商地址": "台北巿復興北路４４０號１樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0251000  RIKEN YAKUKA KOGYO CO., LTD.",
            "製造廠廠址": "4-18, 2-CHOME, HONMACHI, SHIBUYA-KU,TOKYO",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8810600300",
            "成分名稱": "PYRIDOXINE HCL",
            "含量描述": "8.33",
            "含量": "8.3300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004620",
            "成分名稱": "GLYCYRRHIZINATE DIPOTASSIUM (EQ TO DIPOTASSIUM GLYCYRRHIZINATE)",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ]
}